Memorial Şişli Hospital
Xofigo Radium-223 in Turkey typically costs from AUD $9,988 to AUD $14,269, depending on the number of injections required and the clinic tier. In Australia, the average cost for this targeted alpha therapy is around AUD $7,135. By travelling to medical hubs like Istanbul or Ankara, Australians can save approximately 0%. Most Turkish packages include oncologist consultations, medical translations, and airport transfers.
Bookimed Expert Insight: Choosing JCI-accredited hubs like Anadolu Medical Center offers unique value through their affiliation with Johns Hopkins Hospital. While base prices for Xofigo are competitive, patients benefit from protocols designed by globally recognised experts. For instance, specialists like Prof. Dr. Fatih Kurtuluş have received international research awards, ensuring your treatment plan aligns with the latest uro-oncology standards available in Europe.
| Turkey | Thailand | South Korea | |
| Xofigo Radium-223 | from AUD $9,988 | from AUD $10,702 | from AUD $5,850 |
No hidden fees – just official clinic prices. Pay at the clinic for Xofigo Radium-223 upon arrival and use a flexible instalment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Xofigo Radium-223 and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Xofigo Radium-223 journey.
Dr. Basri Cakiroglu is an Associate Professor of Urology at Hisar Hospital Intercontinental in Istanbul. He specializes in urooncology, pediatric urology, and male infertility treatment. Dr. Cakiroglu performs complex surgical interventions using the robotic da Vinci system. He works at a JCI-accredited hospital that serves over 500,000 patients annually.
Professor Mustafa Solak gained specialised expertise at the MD Anderson Cancer Center in the United States – consistently ranked as one of the world's top cancer hospitals.
Dr. Zulfu Sertkaya is an associate professor and andrologist at Andro Expertise in Istanbul. He holds the FEBU title from the European Association of Urology. Dr. Sertkaya focuses on male health, sexual function, and aesthetic urological procedures. He treats patients at his clinic and performs surgeries at affiliated hospitals.
Associate Professor Mehmet Sarier is a leading academic urologist at Istinye University who specialises in treating advanced urological cancers at Medical Park Antalya.
Xofigo (Radium-223) is a targeted internal radiation treatment for prostate cancer that has spread to the bones. In Turkey, patients receive alpha radiation via monthly intravenous injections, which kills bone metastases cells while protecting healthy tissue. It mainly eases bone pain and controls metastases.
Bookimed Expert Insight: Turkey leads global demand with 393 clinics offering Xofigo. Top hospitals in Istanbul combine JCI accreditation and specialised nuclear medicine teams for precise treatment. Patients benefit from outpatient care and coordinated support including interpreters and airport transfers.
Patient Consensus: Patients in Turkey report clear bone pain relief and improved quality of life. They value that treatment avoids surgery and hospital stays. Monitoring focuses on symptom control, making expectations clear upfront.
Xofigo (Radium-223) treatment in Turkey is for men with castration-resistant prostate cancer that has spread mainly to the bones. Patients must have symptomatic bone metastases without significant spread to soft tissues or organs. It is given as monthly intravenous injections, usually after other treatments fail.
Bookimed Expert Insight: Turkey’s top oncology clinics such as Anadolu Medical Center and Memorial Şişli Hospital offer Xofigo treatment aligned with international guidelines. These centres provide personalised follow-up with haematologic monitoring and have a strong patient volume, ensuring well-established protocols for advanced prostate cancer care.
Patient Consensus: Patients in Turkey find Xofigo accessible as a later-line therapy with manageable outpatient visits. Many appreciate that the treatment targets only bone lesions and comes after hormone therapies or chemotherapy, fitting their complex treatment histories.
Xofigo (Radium-223) treatment for prostate cancer in Turkey is given by slow intravenous injection. Specialists deliver six outpatient doses, each spaced four weeks apart, with dosages calculated by body weight. Blood tests monitor patient safety between injections, and radiation safety guidelines are provided after each dose.
Bookimed Expert Insight: Turkey’s top clinics like Memorial Şişli Hospital and Anadolu Medical Center offer Xofigo treatment with full outpatient care and radiation safety briefing. Patients benefit from internationally recognised JCI accreditation and detailed treatment plans, making the experience smooth for Australians travelling back home.
Patient Consensus: Patients recommend confirming dosing and blood test schedules upfront. They appreciate clear radiation safety instructions and outpatient convenience in Turkey. Written treatment plans help avoid surprises during travel and ensure Australian doctors can coordinate follow-up care.
Xofigo (Radium-223) treatment in Turkey targets prostate cancer spreading to bones, easing pain and improving quality of life. It specifically attacks bone metastases while sparing healthy tissue. Leading JCI-accredited hospitals like Memorial Şişli Hospital provide expert care with outpatient injections and minimal recovery time.
Bookimed Expert Insight: Turkey’s top oncology clinics combine JCI quality with large patient volumes, ensuring skilled teams for Xofigo treatments. Istanbul hospitals like Hisar and Medipol Mega serve hundreds of thousands yearly, demonstrating both experience and efficiency for international patients.
Patient Consensus: Patients say Xofigo in Turkey reduces skeletal pain and improves sleep without disrupting daily life. Many appreciate it as part of ongoing prostate cancer care, helping maintain activity and comfort during advanced stages.
Xofigo (Radium-223) treatment for prostate cancer in Turkey commonly causes mild side effects like diarrhoea, nausea, and vomiting. More serious issues include low blood platelet counts, bone fractures, and temporary blood cell reduction. Patients might also feel increased bone pain briefly after treatment.
Bookimed Expert Insight: Turkish clinics like Memorial Şişli Hospital provide Xofigo in Joint Commission International (JCI) accredited centres. Patients with heavy bone disease or weak marrow need careful blood monitoring. Australian patients should organise follow-up blood tests on return home to catch low blood counts early.
Patient Consensus: Many patients in Turkey report increased tiredness after treatment. Some notice temporary bone pain before feeling better. Blood tests are routine and help manage side effects safely.
Xofigo (Radium-223) treatment in Turkey requires standard radiation safety measures to protect others from exposure. Patients must keep excellent hygiene, flush toilets twice, and avoid close contact with children or pregnant people after injections. Clinics like Memorial Şişli Hospital follow international safety protocols.
Bookimed Expert Insight: Turkey’s JCI-accredited hospitals, such as Anadolu Medical Center and Hisar Hospital, are skilled in radiopharmaceutical handling and patient safety. Many clinics provide clear written guidelines on radiation precautions, which help patients manage exposure risks confidently while abroad. Scheduling treatments with enough time before flights avoids logistical stress.
Patient Consensus: Patients in Turkey find Xofigo safety instructions clear and practical. They appreciate that clinics explain hygiene rules and radiation risks well. Careful follow-up planning suits those juggling treatment and travel from Australia.
Australian patients can access Xofigo (Radium-223) treatment for prostate cancer in Turkey at JCI-accredited oncology centres like Memorial Şişli and Anadolu Medical Center. Turkish specialists review medical records to confirm eligibility, then provide radioligand therapy for bone-metastatic prostate cancer with nuclear medicine expertise.
Bookimed Expert Insight: Many top Istanbul cancer centres like Anadolu Medical Center combine JCI accreditation with personal coordinators who assist Australian patients with travel, interpretation and hospital logistics — these extras help smooth the complex Xofigo treatment journey.
Patient Consensus: Australian patients value thorough pre-travel evaluations and clear referral paths for Xofigo in Turkey. Having detailed medical records and committed specialist care both before and after treatment makes the experience more confident and manageable.